Related Experiment Video
Updated: Feb 8, 2026

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Adenotonsillectomy in children with sickle cell disease and obstructive sleep apnea
Annie N Farrell1, Steven L Goudy2, Marianne E Yee3
1Emory University School of Medicine, 1648 Pierce Drive NE, Atlanta, GA, 30307, USA.
Insights
Tonsillectomy and adenoidectomy (T&A) effectively treats obstructive sleep apnea (OSA) in children with sickle cell disease (SCD). This procedure significantly reduced apnea-hypopnea index and emergency room visits, improving patient outcomes.
Area of Science:
- Pediatric Otolaryngology
- Pediatric Hematology
- Sleep Medicine
Background:
- Obstructive sleep apnea (OSA) is common in children, and potentially more severe in those with sickle cell disease (SCD).
- Understanding the risks and benefits of surgical intervention for OSA in this vulnerable population is crucial.
Purpose of the Study:
- To evaluate the therapeutic effects and complications of tonsillectomy and adenoidectomy (T&A).
- To assess the impact of T&A on OSA severity and healthcare utilization in pediatric patients with SCD.
Main Methods:
- Retrospective review of 132 pediatric patients with SCD who underwent T&A between 2010 and 2016.
- Analysis of pre- and post-operative laboratory values, perioperative course, hospital admissions, and polysomnography data.
- Evaluation of emergency room visit frequency before and after surgery.
Main Results:
- T&A was performed on 132 children with SCD, with 72.7% receiving pre-operative transfusions to optimize hemoglobin levels.
- Post-operative polysomnography showed a significant decrease in the Apnea-Hypopnea Index (AHI) and improvement in oxygen saturation nadir.
- Complications occurred in 11.4% of cases, and post-operative emergency room visits decreased significantly.
Conclusions:
- Tonsillectomy and adenoidectomy (T&A) is a safe and effective treatment for obstructive sleep apnea (OSA) in children with sickle cell disease (SCD).
- The procedure leads to significant improvements in sleep study parameters and reduces the need for emergency care.
Introduction:
Obstructive sleep apnea (OSA) is prevalent and may be more severe in children with Sickle Cell Disease (SCD) compared to the general pediatric population.
Objectives:
The objective of this study was to describe the therapeutic effects and complications of tonsillectomy and adenoidectomy (T&A) for treatment of OSA in children with SCD.
Methods:
A comprehensive database of pediatric SCD patients was reviewed to identify all patients who underwent T&A between 2010 and 2016. An IRB-approved, retrospective review of laboratory values, perioperative course, pre- and post-T&A hospital utilization, and polysomnography was conducted.
Results:
There were 132 SCD children (108 HbSS) who underwent T&A. Mean age was 7.6 ± 4.6 years. The mean baseline hemoglobin of these patients was 9.3 ± 1.4 g/dL; 72.7% of patients had pre-operative transfusion, such that the mean Hb at time of T&A was 11.4 ± 1.0 g/dL. The average admission length surrounding T&A was 3.5 ± 1.2 days. Complications were documented in 11.4% of operative cases. Polysomnography was available in 104 pre-T&A and 45 post-T&A. The Apnea-Hypopnea Index decreased on post-T&A polysomnogram (7.6 ± 8.7 vs. 1.3 ± 1.9, p = 0.0001). The O2 nadir improved on post-T&A polysomnogram (81.2 ± 10.8 vs. 89.3 ± 7, p = 0.0003). Emergency room visits (mean events per year) decreased post-operatively (2.6 ± 2.8 vs. 1.8 ± 2.2, p = 0.0002).
Conclusions:
T&A can be a safe and effective option to treat OSA in pediatric patients with SCD and was significantly associated with reduced AHI and fewer ER visits post-operatively.
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment

